Los Angeles Personal Injury Lawyer - All Topics - Most Popular

FBI: Beware of Loan Modification Scams

Paul Kiesel — Tue, 28 Oct 2008 16:08:26 GMT

According to the Justice Department, San Joaquin Valley has been a hotbed for loan modification scams, as cities like Stockton, Modesto and Merced top the foreclosure rankings among cities nationwide.

Last week, Representative Dennis Cardoza (D-Modesto), urged Attorney General Michael Mukasey to investigate mortgage-reduction schemes that are being marketed to distressed homeowners throughout the Valley.

Most of these scams ask homeowners for an upfront fee in order to start a loan modification program. At best, the homeowners may end up paying for work that is completed by the group asking for the money, however, it's work that likely could have been done for free through other non-profit organizations or loan-modification assistance programs (i.e. Community Housing Council, a non-profit based in Fresno). At worst, the homeowners pay for work that isn't done at all.

Cardoza wrote to Mukasey that it was "imperative" that law enforcement authorities "crack down on these foreclosure scams quickly and comprehensively. Cardoza pointed out that San Joaquin Valley residents are particularly vulnerable because of the region's foreclosure crisis.

The scams are typically initiated over the phone or through the mail, however, the people running the scams sometimes show up at the homes they're targeting. The companies will then offer the distressed homeowner their services to renegotiate the mortgage in exchange for an up-front fee amounting to one month's mortgage payment or more.

Just last week, in Modesto, "some homeowners attended a workshop in which they were asked to pay $3,500 for getting their mortgage woes resolved," (San Jose Mercury News, 10/27/08).

The FBI is aware of this problem, as they report to having 1,569 pending mortgage fraud investigations open as of last month. However, it is clear that number will rise and more resources will need to be poured into combating mortgage fraud, as incidences of it has annually doubled between 2003 and 2007.

The FBI has also been taking some flack recently due to their late arrival to all of the rampant mortgage fraud that's been taking place over the last couple years, but part of that is due to the agency not having enough agents to cover the continuing spread of mortgage fraud, as the housing and foreclosure crisis gets worse. The bureau slashed its criminal investigative work force to expand its national security role after the Sept. 11 attacks, shifting more than 1,800 agents, or nearly one-third of all agents in criminal programs, to terrorism and intelligence duties. Current and former officials say the cutbacks have left the bureau seriously exposed in investigating areas like white-collar crime, which has taken on urgent importance in recent weeks because of the nation’s economic woes.

Originally posted at InjuryBoard by Paul Kiesel

Will the FDA Recall Birth Control Products Yasmin & Ocella?

Paul Kiesel — Tue, 25 Aug 2009 18:29:18 GMT

From The Record:

After a birth control pill spent months in the spotlight during commercials aimed at correcting misrepresentations about it, the pill is now at the center of a St. Clair County lawsuit.

Kerry Sims filed a lawsuit Aug. 18 against Bayer and Walgreens, alleging her ingestion of the birth control pill Yasmin, which is also known as Yaz, caused her to experience a blood clot in her lung and infection surrounding the clot.

The suit comes after a commercial warning of some fallacies about the pill repeatedly ran on television for months.

"You may have seen some Yaz commercials recently that were not clear," the ad says. "The FDA wants us to correct a few points in those ads."

It goes on to say Yaz is used to treat the less serious premenstrual dysphoric disorder and moderate acne, not the more serious premenstrual syndrome or mild acne as Bayer once advertised.

But the $20 million Bayer spent on the commercial is not enough for Sims, who says the company failed to warn her about the pill's dangers before she started taking it.

"Plaintiff Kerry Sims reasonably relied upon Defendants' representations to her and/or her healthcare providers that Yaz/Yasmin was safer than other types of oral contraceptives for human consumption and/or use and that Defendants' labeling, advertisements and promotions fully described all known risks of the product," Sims's suit states.

However, such representations were misleading, Sims claims.

In fact, from 2004 through 2008, Yaz has reportedly caused more than 50 deaths, which occurred in some women as young as 17, the complaint says.

"These reports include deaths associated with cardiac arrhythmia, cardiac arrest, intracardiac thrombus, pulmonary embolism, and stroke in women in their child bearing years," the suit states.

The pill's danger possibly stems from Bayer's use of drospirenone, a new type of progestin only used in Yaz and its generic counterpart, Ocella, according to the complaint. The drospierenone causes increased levels of potassium in the blood, which can lead to a condition called hyperkalemia if potassium levels become too high, Sims claims.

In turn, hyperkalemia can cause heart rhythm disturbances, which can then cause the slowing of blood to the heart, allowing for the formation of blood clots. Those clots can lead to heart attacks or can break off and travel to the lungs, causing pulmonary embolism, which is the condition Sims suffered from. In another scenario, the blood clot can travel to the brain where it can cause a stroke, according to the complaint.

Click here for the rest of the article.

Originally posted at InjuryBoard by Paul Kiesel

The Subprime Mess and Phil Gramm: An Experiment in Deregulation

Paul Kiesel — Tue, 24 Jun 2008 16:12:58 GMT

In 1933, a few years following the stock market crash, Congress passes the Glass-Steagall Act, in hopes that regulating banks will help prevent market instability, particularly amongst Wall Street banks. The purpose of the act is to separate commercial banks that focus on consumers from investment banks, which deal with speculative trading and mergers.

The Glass-Steagall Act provided the proper oversight and entity separation that would prohibit banks and other financial companies from merging into giant trusts (conflict of interests) -- giant trusts or corporations being more powerful, naturally, and having the seemingly limitless capital to lobby their corporate interests, however, with a very myopic scope (particularly when it comes to factoring in potential losses -- most banks, as seen in contemporary times, chose not to anticipate losses in the mortgage market; they presumed home prices would continue to appreciate).

In 1999, former Senator Phil Gramm (who is, incidentally, Senator John McCain's economic adviser and cochairs his presidential campaign) set out to completely gut the Glass-Steagall Act, and did so successfully, replacing most of its components with the new Gramm-Leach-Bliley Act: allowing commercial banks, investment banks, and insurers to merge (which would have violated antitrust laws under Glass-Steagall). Sen. Gramm was the driving force behind the Gramm-Leach-Bliley Act, as he had received over $4.6 million from the FIRE sector (Finance, Insurance and Real Estate donations) over the previous decade, and once the Act passed, an influx of "megamergers" took place among banks and insurance and securities companies, as if they had been eagerly awaiting the passage of Gramm's Act. Everything in between Glass-Steagall and Gramm-Leach-Bliley (i.e. Savings and Loan crisis/bust) was, in large part, the incubation period for what would take place over the nine years that would follow the passage of Gramm's Act: an experiment in deregulation.

Shortly after George W. Bush was elected president, Congress and President Clinton were trying to pass a $384 billion omnibus spending bill, and while the debates swirled around the passage of this bill, Senator Phil Gramm clandestinely slipped a 262-page amendment into the omnibus appropriations bill titled: Commodity Futures Modernization Act. It is likely that few senators read this bill, if any. The essence of the act was the deregulation of derivatives trading (financial instruments whose value changes in response to the changes in underlying variables; the main use of derivatives is to reduce risk for one party). The legislation contained a provision -- lobbied for by Enron, a major campaign contributor to Gramm -- that exempted energy trading from regulatory oversight. Basically, it gave way to the Enron debacle and ushered in the new era of unregulated securities. Interestingly enough, Gramm's wife, Wendy, had been part of the Enron board, and her salary and stock income brought in between $900,000 and $1.8 million to the Gramm household, prior to the passage of the Commodity Futures Modernization Act.

In 2003, Gramm left the Senate to join UBS, which had acquired investment house PaineWebber due to his deregulation bill. At UBS, Gramm lobbied Congress, the Fed and the Treasury Department. During Gramm's tenor at UBS and as a lobbyist, Congress passed the Responsible Lending Act, billed as an anti-predatory-lending measure, but was called the "Loan Shark Protection Act" by consumer advocates, as it was designed to preempt stronger state laws against anti-predatory lending. The Fed largely ignored the underlying and growing problems within the subprime mortgage/housing markets, as Bernanke famously acknowledged the housing market in April, 2007 as, "[showing] signs of softening," but said that a "sharp slowdown," is unlikely. Then, according to Mother Jones magazine, Henry Paulson became the Treasury Secretary in July, 2007, when, "In 2005, [at] Goldman [he] securitized $68 billion in residential mortgages and $23 billion in 'other assets' primarily related to CDOs," (Mother Jones, August, 2008). With such self-interest, and a lack of the nation's interest, we can see how this subprime mess was allowed to escalate to such great proportions.

Some justice was served, however, this spring, as UBS became one of the subprime debacle's biggest losers, having to write down $37 billion -- the same amount as their previous four years of profits combined. UBS also made the public aware that two-thirds of its losses were due to reckless investing in collateralized debt obligations (CDOs).

Now, Gramm has a second chance of extending his out-of-touch and ill-performing policies, as Senator John McCain appointed Gramm to be his "economic expert" and cochair of his presidential campaign, last year. Also, it is likely that if Senator McCain were to win in November, Gramm would be our next Treasury Secretary, which means more of the same deregulatory mess and the continuation of failed and insidious economic policies.

Originally posted at InjuryBoard by Paul Kiesel

Another Yaz Birth Control Victim

Paul Kiesel — Tue, 24 Nov 2009 17:58:21 GMT

From Business Wire:

NEW YORK -- Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Mae Walker today filed a personal injury lawsuit against Bayer Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by Bayer’s birth control drug Yaz. Walker’s complaint charges that Yaz is a dangerous prescription drug sold without adequate warnings about the risk of serious injuries.

Walker, age 30, of Belpre, Ohio, works 40 hours a week at McDonald’s and is the mother of three young children. Approximately one year after she started taking Yaz, Walker was diagnosed with deep vein thrombosis (“DVT”), more commonly known as a blood clot, in her left leg. If left untreated, blood clots in the leg can break off and result in life-threatening conditions. Walker was hospitalized for three days, where she received anti-coagulation medication to reduce the swelling in her leg and treat the blood clot.

“Yaz has had a devastating impact on my health and family,” Walker stated. “My work requires me to stand on my feet all day. I still experience leg swelling and cannot lift heavy items. I have to be extremely careful not to ever cut myself due to the blood-thinning medication I am taking, which I have been told I must likely take the rest of my life.”

The complaint charges that Walker would never have developed DVT, been hospitalized, or forced to undergo numerous medical tests and procedures, had Bayer properly warned patients of the dangers of using Yaz.

“The FDA’s adverse event database for Yaz and Yasmin reveal a very high number of serious adverse events associated with these drugs, including strokes, heart attacks, blood clot formation, gallbladder and kidney disease, and sometimes death,” commented attorney Fleishman. “Bayer failed to warn doctors and consumers that Yaz and Yasmin are actually more dangerous than previous generations of oral contraception pills.”

The complaint was filed in the Superior Court of New Jersey, where Bayer Healthcare Pharmaceuticals, Inc., is located.

Click here for the rest of the article.

**Also, anyone who has been adversely affected due to taking these prescription drugs, like Yasmin, Yaz or Ocella, should get in touch with Helen Zukin. Ms. Zukin recently retained a client, a young woman, who unfortunately suffered from a stroke, after only taking Ocella (generic version of Yaz) for a month.

Originally posted at InjuryBoard by Paul Kiesel

Message to Archbishop Joseph F. Naumann: Leave Gov. Kathleen Sebelius Alone

Paul Kiesel — Tue, 10 Mar 2009 16:15:20 GMT

Archbishop Joseph F. Naumann of Kansas City has been spewing his vile opinions in regards to President Obama's selection of Kansas Governor Kathleen Sebelius as the Health and Human Services secretary nominee with several media outlets this week. These opinions include: being openly, however, unfairly critical of the governor and her political party (i.e. Vice President Joe Biden, California Senator Nancy Pelosi, etc.), suggesting her political and social views are evil or wicked ("Such acts [abortion] are judged to be intrinsically evil..."), and he has called for the Catholic Church to deny Governor Sebelius communion.

First, Archbishop, Governor Sebelius has maintained that her Catholic faith is the basis of her belief that "life is sacred." She INSISTS that her personal belief is that abortion is wrong. However, bullying her to try and criminalize abortion will not stop the practice of abortion, but only make it more deadly. Governor Sebelius has stated several times that her goal is to implement policy to prevent unwanted pregnancies, obviously in a hope to lessen the number of abortions that take place in the U.S.

And the Governor will likely have the opportunity as HHS secretary to make several policy changes in an effort to reduce the amount of abortions that take place in this country, but that will only occur if the number of unwanted pregnancies decreases, as well. However, I'm sure the Archbishop will oppose that, too, since his church is adamantly against the use of condoms, except in the most narrow circumstances (and that latter exception is only a recently amended doctrine rule).

Now the Catholic Church and Archbishop Naumann will state that 100 percent extramarital abstinence will prevent unwanted pregnancies and abortions. See, the problem with this argument is 1) That'll never occur. Never. We're humans. We're mammals. And sex is natural. And it'll naturally occur among teenagers, young adults and other non-married couples. 2) These guys, the clergy and other leaders within the Catholic church, can't even practice what they preach. Just because they're not having sex with consenting adults, doesn't make sex with children morally correct.

Archbishop Naumann is essentially saying that the Catholic Church's doctrine should dictate public policy. He wants to surreptitiously make church and state one in the same. And if the Archbishop had his way, his views on all church doctrine being vigorously enforced, then condoms would be prohibited. In fact, Archbishop Namann and his church's doctrine essentially sacrifices the lives of thousands of women each year. For instance...

Human Papillomavirus (HPV) is now the most common sexually transmitted disease in the United States. The virus infects over half the American population and causes nearly five thousand women to die each year from cervical cancer; the Center for Disease Control (CDC) estimates that more than two hundred thousand die worldwide. We now have a vaccine for HPV that appears to be both safe and effective. The vaccine produced 100 percent immunity in the six thousand women who received it as part of a clinical trial. And yet, Christian conservatives [and Catholic conservatives] in our government have resisted a vaccination program on the grounds that HPV is a valuable impediment to premarital sex. These pious men and women want to preserve cervical cancer as an incentive toward abstinence, even if it sacrifices the lives of thousands of women each year.

Sam Harris, "Letter to a Christian Nation"

There is nothing wrong with discouraging teenagers from having sex at a young age. But, as seen by Sarah Palin and her daughter's unwanted pregnancy, abstinence only is not a good way to curb teen pregnancy nor is it the responsible approach to prevent the spread of sexually transmitted diseases.

Also, in preemption to the Catholic Church's uproar in regards to President Obama lifting the Bush ban on embryonic stem-cell research, that I'm sure will be heard vociferously later today or this week, your qualms and complaints are similarly obtuse.

Until you guys (Archbishop Naumann, Cardinal Mahony, Dolan, etc.) quit contradicting yourselves, quit acting in nefarious ways when it come to clergy sex abuse matters, quit saying you appreciate all forms of life, when in fact that's a flat out lie (i.e. see the church's recent views on most things scientifically progressive; the Catholic church seemingly wants society to be shackled in the ways and mores of medieval Europe, much like Islamic-extremists would like us to revert to the Stone Age) then most people, rational people, do not want to hear anything you've got to say.

Most of your opinions and belief are anachronistic and invalid. So leave Governor Sebelius alone.

Originally posted at InjuryBoard by Paul Kiesel

Bayer Follows Google's Lead

Paul Kiesel — Wed, 18 Nov 2009 19:59:37 GMT

Bayer's Yaz is trying out a paid search format similar to that proposed by Google for products carrying black-box warnings.

The Yaz-branded sponsored link appears in a yellow-highlighted box atop Google searches on terms including “Yaz,” “the pill” and “birth control.” It features a headline linking to the product site, a line of text advising viewers to “Read important product info here,” and a bottom line reading “Click to see full safety and prescribing information, including boxed warning,” followed by a “fixed” link to physician labeling.

Yaz carries a boxed warning of sharply increased cardiovascular risks for users who smoke, particularly those over the age of 35. Boxed warnings denote particularly serious risks and prescription drug brands carrying boxed warnings are not allowed to run so-called reminder ads giving a brand name but not its indication.

Bayer was among the 14 recipients of untitled letters for violative sponsored links issued by FDA's Division of Drug Marketing, Advertising and Communications in April. Drug companies had been operating under the so-called “One click rule,” the assumption that as long as full-risk information was a click away, they could run space-limited sponsored links giving only a name and abbreviated indication [. . .]

Click here for the rest of the article.

Originally posted at InjuryBoard by Paul Kiesel

Maclaren Stroller Defect Went Unfixed for Five Years

Paul Kiesel — Thu, 19 Nov 2009 19:15:53 GMT

From the New York Post:

Maclaren knew for at least five years that its strollers could lop off a child's finger, but did nothing about the dangerous defect until federal regulators all but forced it to, The Post has learned.

This week, the company agreed to a "voluntary recall" of all its models sold as far back as 1999, conceding that the fingers of 12 children were severed by the stroller's hinges when they were opened or closed.

But since Maclaren failed to notify the Consumer Products Safety Commission when it first became aware of even a "potential danger," the British-based company could still face a fine of $1 million or more, sources said.

Companies are required by federal law to "report to CPSC immediately on learning of a problem with a product that makes it a substantial hazard or poses a potential hazard," commission spokesman Scott Wolfson said.

The company has known the stroller hinges could become finger guillotines since at least July 12, 2004, when 23-month-old Connecticut toddler Carlos DeWinter lost his right pinky, according to court papers obtained by The Post.

His mother, Jane DeWinter, was shopping for a Maclaren Triumph stroller at a Right Start shop near her Greenwich home, and she was testing the one-handed folding and unfolding mechanism.

As she was about to lock the stroller into the open position, Carlos put his finger on the hinge, and he suffered a "traumatic amputation," the court papers said.

Despite two surgeries, the pinky could not be reattached.

Maclaren and Right Start argued that the mother's "own negligence" was to blame, the suit says.

Click here for the rest of the article.

Originally posted at InjuryBoard by Paul Kiesel

Washington Post: The Bubble - An Excellent Survey of the Subprime Lending Debacle

Paul Kiesel — Mon, 16 Jun 2008 20:37:15 GMT

This past weekend, The Washington Post began a three-part series that examines all of the avarice, pride, and myopic lending during the subprime boom.

Overall, the series, written by Alec Klein and Zachary A. Goldfarb, is an indictment on the lack of government oversight and regulation within the lending industry, which led to irresponsible lending (teaser rate loans; subsequently being packaged as mortgaged-back securities or collateralized mortgage obligations) and opaque accounting, thus, paving way to the economic contraction the country has faced over the last 16 months.

Here are links to the articles: (Article 1); (Article 2)

As noted in the article, with the help of two big tax cuts pushed by the Bush Administration in 2002 and 2003, and interest rates having been slashed by the Fed, lending and spending became two words analogous with this administration. However, as far as fixing the housing mess or dealing with its ramifications, the current administration, in its last six months, has done little to help relieve homeowner distress, even though it help prompt the crippling consequences this country is now seeing. We'll have to wait and see what type of impact the Bush Administration will have on the mortgage crisis and Wall Street, as it vacates the White House.

Originally posted at InjuryBoard by Paul Kiesel

If You Have an Option ARM Loan with FDIC IndyMac, Read This!

Paul Kiesel — Fri, 10 Oct 2008 21:47:57 GMT

Any Californian who has a Pay Option ARM loan from IndyMac (now FDIC IndyMac) that was originated between 2004 and 2007 and has faced or will be facing an interest rate reset (ballooned monthly payment), should contact the bank or seek legal counsel before next Friday, October 14.

According to the FDIC, Option ARM borrowers have 90 days to respond to the notice of IndyMac being taken over by the federal government, if they want to be able to modify their loan or take legal action against IndyMac. When does the 90 day period end? October 14. Where did the notice come from? The FDIC claims that when newspapers reported that the Office of Thrift Supervision transferred control of IndyMac to the FDIC, on July 11, the newspaper articles throughout the State of California served as a notice to the public.

However, most borrowers of Option ARM loans never got a formal notice. Regarding this issue, the only notices that have been sent out are to named plaintiffs in class action lawsuits against IndyMac Bancorp. In fact, the FDIC has refused to notify other Californian consumers of Option ARM loans that their time to take action is running out, and this is a big problem because tens of thousands of Option ARM borrowers have been left in the dark and do not realize that the date is rapidly approaching for them to seek a fair remedy to their troubled mortgage situation (or pending situation).

The FDIC has a contact number listed on their website under the page titled: FDIC Loan Modification Program for Distressed IndyMac Mortgage Loans. On the bottom of this page it states: Borrowers who are delinquent or who are experiencing financial hardship and are falling behind on their IndyMac Federal mortgage should call 1-800-781-7399 to speak with an IndyMac Federal customer service representative.

Originally posted at InjuryBoard by Paul Kiesel

Associated Press: KV Pharmaceutical and Ethex Recall Morphine Sulfate Tablets and 17 Other Generic Products Due to Potential Life Threatening Consequences from Oversized Tablets

Paul Kiesel — Tue, 18 Nov 2008 21:03:56 GMT

On Friday, November 7, 2008, the Associated Press reported that Ethex Corporation, a manufacturer of the pain medication Morphine Sulfate, is voluntarily recalling five of their generic drug brands due to reports of tablets being as much as twice the size and potency as the labeled active ingredient levels suggests.

Morphine Sulfate is one of the five generic drugs that Ethex is recalling. However, this is not the first recall that's been issued on Ethex Corp.'s Morphine Sulfate drug this year.

On June 10, 2008 the FDA issued a MedWacth E-mail Alert on Ethex Corp.'s "Morphine Sulfate 60 mg Extended Release Tablets - Recall of a Single Lot to a Report of a Tablet with Twice the Appropriate Thickness." The FDA warned then that any consumers that begin or continue to take this drug are at the risk of morphine overdose which could lead to breathing problems, erratic behavior, seizures, low blood pressure, nausea, vomiting and even death.

A few days after the FDA issued its MedWatch Alert, Ethex expanded its morphine pill recall to include specific lots of morphine sulfate 60 mg extended release tablets and of 30 mg tablets. These recalled lots were distributed between June 2006 and May 2008.

On October 15, 2008, Ethex released a voluntary recall to the consumer level of three specific lots of dextroamphetamine sulfate 5mg tablets, due to the presence of oversized tablets being reported by two pharmacists. A second recall on Morphine Sulfate was issued three weeks later and Ethex expanded this recall effort to include Propafenone HCI, Isosorbide Mononitrate and Dextroamphetamine Sulfate, which are all manufactured under the brand name "ETHEX."

The Morphine Sulfate tablets that have been recalled have labeled potency levels of 15mg, 30 mg, and 60 mg tablets (see below for specific lots).

In all, over 18 generic and non-branded products have been recalled in 2008 by Ethex and/or its parent company KV Pharmaceutical.

No report of any oversized tablets from any of the lots of the products involved in these June, October and November recalls has been received by ETHEX from any wholesaler, retailer, consumer or caregiver.

We are in the process of compiling all of the lot numbers and product descriptions for all 18 drugs that have been recalled from June through November 2008.

Below is a list of the lots involved in the recall that were shipped prior to May 22, 2008 and are as follows:

Propafenone HCl Tablets, 150 mg: Lots: 73761, 78184, 79373, 81240, 81241, 81242, 83470, 84357, 90525, and 90526 with expiration dates ranging from 3/2009 to 3/2011

Propafenone HCl Tablets, 225 mg: Lots: 71720, 74831, 76014-15, 81243-45, 89731, 90527-29, and 90657 with expiration dates ranging from 3/2009 to 2/2011

Propafenone HCl Tablets, 300 mg: Lots: 72834, 76016-18, 81246, 89092, 89732, 90530, 90532, and 91641-42 with expiration dates ranging from 6/2009 to 3/2011

Isosorbide Mononitrate Extended Release Tablets, 30 mg: Lots: 62355, 66423, and 68102 with expiration dates ranging from 11/2008 to 8/2009

Isosorbide Mononitrate Extended Release Tablets, 60 mg: Lots: 63466, 66034, 67351, and 67354 with expiration dates ranging from 12/2008 to 11/2009

Morphine Sulfate Extended Release Tablets, 15 mg: Lots: 81175, 82514-16, 89660, 89664, 89667, 90249-51, and 91687 with expiration dates ranging from 12/2008 to 2/2010

Morphine Sulfate Immediate Release Tablets, 15 mg: Lots: 77852-54, 81746, 82519-20, 84113, and 90276-78 with expiration dates ranging from 9/2009 to 1/2011

Morphine Sulfate Immediate Release Tablets, 30 mg: Lots: 75093, 77855-57, 82297, 82521-22, 87239, 88925, and 90288-98 with expiration dates ranging from 8/2009 to 3/2011

Dextroamphetamine Sulfate Tablets, 10 mg: Lots: 73934, 75892, 77945, 81137, 86320 with expiration dates ranging from 6/2009 to 5/2011

The 150 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with “ETH” on one side and “331” with a bisect on the reverse. The 225 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with “ETH” on one side and “332” with a bisect on the reverse. The 300 mg Propafenone Hydrochloride Tablets is a white, scored round film coated tablet with “ETH” on one side and “333” with a bisect on the reverse.

The 30 mg Isosorbide Mononitrate Extended Release Tablet is an oval, reddish-pink, film-coated tablet with a debossed “E” bisecting “30” on one side and bisect on the other side. The 60 mg Isosorbide Mononitrate Extended Release Tablet is an oval, yellow film-coated tablet with a debossed “E” bisect “60” on one side and bisect on the other side.

The 15 mg Morphine Sulfate Extended Release Tablet is a green oval tablet with “15” on one side and an “E” on the reverse. The 15 mg Morphine Sulfate Immediate Release Tablet is a round brown tablet with a “15” on one side and an “ETH” on the reverse. The 30 mg Morphine Sulfate Immediate Release Tablet is a capsule shaped brown tablet with “30” on one side and an “ETHEX” on the reverse.

The 10 mg Dextroamphetamine Sulfate Tablet is a round, flat-face, bevel edge, orange mottled tablet debossed “ETHEX” and “312” on one side and double-scored on the other side.

Originally posted at InjuryBoard by Paul Kiesel